Associate Professor of Medicine, Beth Israel Deaconess Medical Center
Cardiology
Dr. Francine K. Welty, MD
|
|
Give Review
Francine K. Welty, MD works in the field of Cardiology. He graduated from Case Western Reserve University School of Medicine. He received 2 awards: "Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Francine Welty is a published doctor and has 72 publications published. The lastest was: 'Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.' Francine Welty accepts Medicare.
Publications
- Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.
- A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study.
- Hypobetalipoproteinemia and abetalipoproteinemia.
- Assessment of liver fat in an obese patient population using noncontrast CT fat percent index.
- How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?
- Comparison of Coronary plaque subtypes in male and female patients using 320-row MDCTA.
- Treating to target: implementing an effective diabetes care paradigm for managed care.
- Effect of soy nuts on adhesion molecules and markers of inflammation in Hypertensive and normotensive postmenopausal women.
- Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
- Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women.
- Effect of onsite dietitian counseling on weight loss and lipid levels in an outpatient physician office.
- Effect of soy nuts on blood pressure and lipid levels in Hypertensive, preHypertensive, and normotensive postmenopausal women.
- The association between soy nut consumption and decreased menopausal symptoms.
- Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
- LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures.
- Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.
- Influence of the DASH diet and other low-fat, high-carbohydrate diets on blood pressure.
- TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
- Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).
- Stable isotopes in obesity research.
- Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
- The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.
- Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic Syndrome.
- Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
- Preventing clinically evident Coronary heart disease in the postmenopausal woman.
- Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
- Lipoprotein metabolism in subjects with hepatic lipase deficiency.
- Nutrition and Women's Health Symposium. Introduction.
- Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with Coronary heart disease to reach Adult Treatment Panel III low-densi...
- Resolution of NASH with weight loss documented by hepatic MRI.
- Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children.
- Metabolic Disease risk in children by salivary biomarker analysis.
- Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable Coronary heart disease in the Treating to New Targets (TNT) study.
- Pseudallescheria boydii endocarditis of the pulmonic Valve in a liver transplant recipient.
- Purification of the "corrinoid" enzyme involved in the synthesis of acetate by Clostridium thermoaceticum.
- Donor splice-site mutation (210+1G_C) in the ApoB gene causes a very low level of ApoB-100 and LDL cholesterol.
- Cholesterol and apolipoprotein B metabolism in Tangier Disease.
- Women and cardiovascular risk.
- Reasons for higher in-hospital mortality >24 hours after percutaneous transluminal Coronary angioplasty in women compared with men.
- Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma.
- Human apolipoprotein A-IV metabolism within triglyceride-rich lipoproteins and plasma.
- Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EB...
- Cardiovascular Disease and dyslipidemia in women.
- Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans.
- Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans.
- Optimal management of non-ST segment elevation Myocardial infarction remains unclear.
- Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.
- Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.
- Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins.
- Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion.
- Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.
- Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population.
- Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies.
- Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes.
- Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population.
- Purification of the apolipoprotein B-67-containing low density lipoprotein particle and its affinity for the low density lipoprotein receptor.
- A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal Coronary angioplasty for postinfarction ischemia and an ...
- Similar results of percutaneous transluminal Coronary angioplasty for women and men with postmyocardial infarction ischemia.
- Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study.
- Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of Acute myocardial infarction in patients undergoing percutaneous transluminal...
- Identification and molecular analysis of two apoB gene mutations causing low plasma cholesterol levels.
- Intra-Aortic balloon counterpulsation support in the high-risk cardiac patient undergoing urgent noncardiac surgery.
- A truncated species of apolipoprotein B (B67) in a kindred with familial hypobetalipoproteinemia.
- Preoperative evaluation for diabetic renal transplantation: impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival.
- Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable Coronary heart disease.
- Alternative hormone replacement regimens: is there a need for further clinical trials?
- Measuring noncalcified Coronary atherosclerotic plaque using voxel analysis with MDCT angiography: a pilot clinical study.
- Apolipoprotein B metabolism in humans: studies with stable isotope-labeled amino acid precursors.
- Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid Syndrome.
- Atorvastatin and cardiovascular risk in the elderly--patient considerations.
- Lasofoxifene and cardiovascular events in postmenopausal women with osteoporosis: Five-year results from the Postmenopausal Evaluation and Risk Reduction with Lasofoxi...
Schools
Case Western Reserve University School of Medicine
Johns Hopkins
Beth Israel Harvard
Jefferson Med College
Harvard Med School
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Coronary Angioplasty, Atherectomy and Stent
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomegaly
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- EBS-RMSCO
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Golden Rule
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- Simplifi
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Beth Israel Deaconess Medical Center -
Tufts Medical Center -
Johns Hopkins University -
Case Western Reserve University School of Medicine
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1538191051 | |
| NPPES Provider LastName | WELTY | |
| NPPES Provider FirstName | FRANCINE | |
| NPPES Provider ZIPCode | 02215 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 239.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538191051 |
| Last Name Of The Provider | WELTY |
| First Name Of The Provider | FRANCINE |
| View All |
Similar Doctors
|
|
Dr. Kibar Yared, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Kiernan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ralph M. Debiasi, MD |
|
|
Dr. Kevin J. Croce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin J. Rafferty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley A. Maron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc P. Bonaca, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kush Agrawal, MD
This Doctor is OpenDoctor Recommended.
|